• Nie Znaleziono Wyników

Interventional catheterization for congenital heart defects: what can we do for others? Project Rwanda

N/A
N/A
Protected

Academic year: 2022

Share "Interventional catheterization for congenital heart defects: what can we do for others? Project Rwanda"

Copied!
2
0
0

Pełen tekst

(1)

385

Letter to the Editor

Corresponding author:

Prof. Jacek Białkowski MD, PhD, Department of Congenital Heart Defects and Paediatric Cardiology, Medical University of Silesia, Silesian Centre for Heart Diseases, 9 M. Curie-Sklodowskiej St, 41-800 Zabrze, Poland, phone/fax: +48 32 271 34 01, e-mail: jabi_med@poczta.onet.pl Received: 16.07.2019, accepted: 9.08.2019.

Interventional catheterization for congenital heart defects: what can we do for others? Project Rwanda

Jacek Białkowski

Department of Congenital Heart Defects and Paediatric Cardiology, Medical University of Silesia, Silesian Centre for Heart Diseases, Zabrze, Poland

Adv Interv Cardiol 2019; 15, 3 (57): 385–386 DOI: https://doi.org/10.5114/aic.2019.87903

Interventional catheterization has nowadays become the method of choice in treatment of several congenital heart defects (CHD). It is also developing quickly in Po- land. The number of transcatheter procedures reached a similar number to cardiac surgery procedures in CHD in 2018 (2293 vs. 2271) [1]. Our interest in international collaboration and development of interventional cardiol- ogy in CHD has been evolving for many years. Recent- ly, we were awarded by the Polish Cardiac Society for 24 articles published in the years 2012–2017 [2]. In 2007 we started in our centre an educational programme for young interventional CHD cardiologists from different countries. Since then, we have trained 23 cardiologists (all below 40 years old) from different countries in Europe (Ukraine, Belarus, Bulgaria, Georgia, Italy, Russia), Latin America (Mexico, Colombia, Bolivia, Guatemala, Argen- tina), Asia (Uzbekistan, China) and Africa (Rwanda). The training period varied from 1 to 12 months.

A Letter to the Editor titled ‘Percutaneous treatment of CHD, what was new in 2014’ was recently published in Kardiologia Polska [3], describing, among other top- ics, my idea of a mobile cath-lab laboratory mounted on a truck for Africa needs. Despite the fact that we received support from a key person of the World Health Organi- zation (WHO) and the Vatican, unfortunately, the latter project has not developed further. Also interest showed by African paediatric cardiologists in this idea (presented by me) during the CSI Africa Congress in Addis Ababa in December 2014 and the CSI in Frankfurt (main con- gress) in June 2015 was moderate. I have started to think that something is wrong and that the idea might be too general and I  should change the strategy [4]. The next step was my “tourist” visit to Rwanda in 2018 and fel- lowship of Dr Yves Mutabandama in 2019 in our centre

(Silesian Centre for Heart Diseases, Zabrze). He is well educated, finishing his paediatric cardiology training at Kigali Teaching University in Rwanda. Rwanda is a small African, equatorial country. It has only 26 000 square km and a population of 12.5 million habitants (60% children) with a stormy contemporary history. However, now it has become a  politically and economically stable country.

As in many other Central and Eastern Africa countries, there are no regular cardiac catheterizations laboratories.

In Rwanda some simples percutaneous interventions in CHD were performed only during a  few missions orga- nized by a charity organization from Europe (the Chain of Hope, Belgium) with an X-ray C arm [5]. As we discussed with Dr Joseph Mucumbitsi (an experienced cardiologist) during my visit to Rwanda in 2018 and Dr Mutabandama, the need to organize a permanent cath lab in Rwanda, not only for treatment of CHD patients, but also for adult coronary artery disease procedures, is fundamental. It is a  big project that will need strong support from many institutions, especially the Rwanda Ministry of Health.

Economic support to build a cath lab and logistic support to educate all medical staff – nurses, technicians, medical doctors – will be needed. In my opinion, many interna- tional organizations such as WHO, charity foundations, European Society of Cardiology (ESC), and European As- sociation of Percutaneous Cardiovascular Interventions (EAPCI) can do a lot in this field. There is also a place for Polish institutions such as PTK (Polskie Towarzystwo Kar- diologiczne) and AISN (Asocjacja Interwencji Sercowo- -Naczyniowych).

In conclusion, the idea of a mobile cath lab for Africa is not feasible. A more practical and useful strategy is to organize a fully equipped, traditional cath lab with finan- cial, logistic and personal support.

Creative Commons licenses: This is an Open Access article distributed under the terms of the Creative Commons

Attribution-NonCommercial-ShareAlike 4.0 International (CC BY -NC -SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/).

(2)

Jacek Białkowski, Project Rwanda

386 Advances in Interventional Cardiology 2019; 15, 3 (57)

Conflict of interest

The author declares no conflict of interest.

References

1. Białkowski J, Szkutnik M, Powałka A. Interventional catheteriza- tion in pediatric catheterization laboratories for congenital and structural heart defects during 2009–2018 in Poland. Report of the National Consultant of Pediatric Cardiology. Adv Interv Car- diol 2019; 15: 374-6.

2. Białkowski J. Progress in the interventional treatment of con- genital and structural heart defect – scientific award of the Pol- ish Cardiac Society. Kardiol Pol 2018; 76: 68-9.

3. Bialkowki J. Interwencyjne leczenie wrodzonych i strukturalnych wad serca: co nowego w 2014 roku? Projekt mobilnej hemody- namiki dla krajów rozwijających się. Kardiol Pol 2015; 73: 69-71.

4. Bialkowski J. Mobile cathlab for the treatment of congenital heart defects – is it real idea? My own experience and example of Rwanda. Congenital Cardiol Today 2018; 16: 9-13.

5. Senega J, Rusingiza E, Mucumbitsi J, et al. Catheter interventions in congenital heart diseases without regular catheterization lab- oratory equipment: the Chain of Hope experience in Rwanda.

Ped Cardiol 2013; 34: 39-45.

Cytaty

Powiązane dokumenty

Fifteen patients received surgical repair of con- genital heart defects including atrial septal defect plus pulmonary stenosis in 1, coarctation of the aorta in 9, and

There is increas- ing use of implantable cardioverter-defibrillators (ICD). Such devices are applied predominantly in patients after Fallot repair, with congenitally cor-..

1131 Jacek Białkowski, Małgorzata Szkutnik, Amplatzer devices in the percutaneous treatment of congenital heart defects in children and adults.. w

This point concerns several other important topics such as our positive experience in the percutaneous closure of patent foramen ovale in a case of cryptogenic stroke in children

1 Department of Congenital Heart Defects and Paediatric Cardiology, SMDZ in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases, Zabrze, Poland..

A 3D heart model based upon CT data was fabricated (Zortrax M200) 3 months after the surgery to explore the anatomy of the central shunt, the growth of pulmonary

w Chicago, poinformo- wano, że wkrótce rozpocznie się rekrutacja pacjentów do wykonywania badań pilotażowych w Europie w wybranych ośrodkach (m.in. w Londynie i we

The most frequently observed defects include: ventricular septal defect (20 cases), atrioventricular septal defect (7 cases), coarctation of the aorta (5 cases) and hypoplastic